男性乳腺癌:当前情景和未来的前景
Anitha Chidambaram1, Rajkumar Prabhakaran2, Sivabalan Sivasamy2
1Department of Biochemistry, PRIST Deemed to be University, Thanjavur, TN, India.
Technology in cancer research & treatment
|July 23, 2024
概括
男性乳腺癌 (MBC) 是罕见的,但在增加. 尽管有风险因素和独特的特征,但研究和量身定制的治疗方法仍滞后,需要进行跨国研究以改善患者护理.
科学领域:
- 在瘤学瘤学.
- 男人的健康 男人的健康
- 癌症研究 癌症研究
背景情况:
- 男性乳腺癌 (MBC) 占全球所有乳腺癌的1.8%,每年发病率增加1.1%.
- 在过去的十年中,发病率从7.2%上升到10.3%,而死亡率从11%下降到3.8%.
- 尽管诊断的增加,但在MBC的特征存在一个显著的差距,即使在发达国家.
研究的目的:
- 审查目前对男性乳腺癌 (MBC) 流行病学,风险因素和临床特征的理解.
- 突出由于缺乏MBC特定研究的诊断和治疗挑战.
- 强调需要不同的临床方法和跨国合作,为MBC患者的护理.
主要方法:
- 在文献中搜索男性乳腺癌 (MBC) 的研究.
- 对流行病学数据,风险因素,分类,症状,诊断和治疗方法的分析.
- 与女性乳腺癌 (FBC) 进行MBC特征和治疗的比较.
主要成果:
- 关键的MBC风险因素包括晚年,遗传倾向,环境暴露,荷尔蒙失衡和特定的荷尔蒙受体表达.
- MBC呈现出类似于女性乳腺癌 (FBC) 的症状,通过超声波,乳房影像和活检诊断.
- 目前的治疗指南在很大程度上是从FBC中推断出来的,因为MBC特定的前性研究有限.
结论:
- 男性乳腺癌 (MBC) 呈现出独特的临床和分子特征,需要专门的研究.
- 发展MBC的独特诊断和治疗策略至关重要.
- 跨国协作努力对于推进瘤学家改善男性乳腺癌患者护理的能力至关重要.
相关概念视频
01:21Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K